The Animal Core C will perform a variety of services for individual projects related to the utilization and evaluation of bleomycin-treated mice.
The Specific Aims of the Animal Core include: 1. Providing a standardized model of bleomycin-treated mice to other components of the SCOR program. The lungs will be assessed histologically and biochemically for evidence of fibrosis. The Core will administer potential therapeutic agents and assess their activity in this murine model of pulmonary fibrosis. 2. Developing and/or maintaining transgenic mice strains utilized in the various components of the SCOR program. The Core will perform a variety of specialized functions on bleomycin- treated wild-type and transgenic animals for individual projects within the program. These procedures include the placement of osmotic pumps, RNA isolation and Northern blot analysis of lung tissue, in situ hybridization, and immunohistochemistry. The goal of the Core is to provide an easily accessible animal model to explore new ideas in the pathogenesis and treatment of pulmonary fibrosis.
| Akuthota, Praveen; Capron, Kelsey; Weller, Peter F (2014) Eosinophil purification from peripheral blood. Methods Mol Biol 1178:13-20 |
| Bandeira-Melo, Christianne; Weller, Peter F (2005) Mechanisms of eosinophil cytokine release. Mem Inst Oswaldo Cruz 100 Suppl 1:73-81 |
| Segel, Michael J; Izbicki, Gabriel; Cohen, Pazit Y et al. (2003) Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L1255-62 |
| Lucey, Edgar C; Goldstein, Ronald H; Breuer, Raphael et al. (2003) Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema. Respiration 70:200-5 |
| Subramaniam, Meera; Sugiyama, Kumiya; Coy, David H et al. (2003) Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med 168:601-11 |
| Izbicki, Gabriel; Or, Reuven; Christensen, Thomas G et al. (2002) Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice. Am J Physiol Lung Cell Mol Physiol 283:L1110-6 |
| Bandeira-Melo, Christianne; Hall, John C; Penrose, John F et al. (2002) Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol 109:975-9 |
| Ricupero, D A; Poliks, C F; Rishikof, D C et al. (2001) Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 281:C99-C105 |
| Bandeira-Melo, C; Sugiyama, K; Woods, L J et al. (2001) Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol 166:4813-7 |
| Bandeira-Melo, C; Phoofolo, M; Weller, P F (2001) Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem 276:22779-87 |
Showing the most recent 10 out of 45 publications
